Promo !

Retatrutide/Cagrilitide 10 mg + 5 mg

Le prix initial était : $200.00.Le prix actuel est : $160.00.

People can lose weight on cagrilintide. Clinical trials show that using cagrilintide alone helps reduce body weight by roughly 11% to 12% over extended periods. When paired with semaglutide as a combination treatment called CagriSema, weight loss results are even higher, often exceeding 20%.

Retatrutide/Cagrilitide 10 mg + 5 mg research-grade lyophilized powder supplied in a sealed glass vial. This dual-compound formulation is studied in experimental models of metabolic regulation, appetite signaling and energy balance via incretin and amylin-related pathways.

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.

 

Purity
High-purity research grade

 

Form
Lyophilized powder

 

Content
Retatrutide 10 mg + Cagrilitide 5 mg (15 mg total) per vial

 

Total content
15 mg combined lyophilized peptide

 

Packaging
Sealed glass vial with sterile stopper

 

Storage
Store in a cool, dry place. Recommended storage below 18 °C.

 

Molecular formula
Not specified (peptide compounds)

 

Molecular weight
Not specified (peptide compounds)

 

IUPAC name
Retatrutide; Cagrilitide

 

CAS number
Retatrutide: 2381089-83-2
Cagrilitide: 1415456-99-3

Retatrutide/Cagrilitide 10 mg + 5 mg

Research Overview

Retatrutide and cagrilitide are synthetic peptide analogues studied in advanced metabolic research. Retatrutide is investigated for its multi-receptor activity within incretin pathways, while cagrilitide is explored as a long-acting amylin analogue. In experimental settings, this combination is used to study appetite regulation, energy expenditure, glucose handling and metabolic signaling integration.

Primary Research Areas

  • Incretin & amylin signaling pathways: used to investigate combined modulation of GLP-1, GIP, glucagon and amylin-related receptor systems in metabolic research models.
  • Energy balance & appetite regulation: applied in experimental studies examining food intake behavior, satiety signaling and central–peripheral metabolic communication.
  • Glucose metabolism & insulin dynamics: explored in preclinical models assessing glycemic control, insulin sensitivity and pancreatic signaling responses.
  • Body-weight regulation models: studied in animal models of obesity and metabolic dysfunction to evaluate synergistic effects on adiposity and energy expenditure.
  • Neuroendocrine & metabolic integration: investigated for interactions between central appetite circuits, peripheral hormone signaling and adaptive metabolic responses.
Reconstitution

Recommended solvent — Bacteriostatic water

Bacteriostatic water 10ml
Individual Mechanisms
  • Retatrutide: A triple-hormone receptor agonist (GLP-1, GIP, and glucagon receptor triagonist) that stimulates insulin secretion, slows gastric emptying, suppresses appetite, and significantly increases energy expenditure/fat burning. [1, 2, 3]
  • Cagrilintide: A long-acting amylin analog that targets amylin and calcitonin receptors in the brain to enhance satiety and complement the fullness signals driven by incretin pathways. [1, 2]
Proposed Combination Rationale
  • Complementary Pathways: Retatrutide handles GLP-1/GIP/glucagon signaling, while Cagrilintide provides parallel amylin-based hindbrain satiety signaling.
  • Gastric Slowdown: Both compounds independently delay gastric emptying, potentially extending post-meal fullness. [1, 2]
Clinical Status and Safety
  • Investigation Only: Neither compound is FDA-approved as a combined commercial product for weight loss or diabetes, and formal synergistic dosing guidelines for a fixed 10 mg + 5 mg ratio have not been established in standard clinical prescribing information. [1]
  • Side Effects: Common adverse events across clinical evaluations of these classes are primarily gastrointestinal, including severe nausea, vomiting, diarrhea, and constipation. [1, 2]
If you are looking for specific details, please let me know:
  • Are you looking for reconstitution or mixing calculations for research vials?
  • Are you trying to understand clinical trial data for these specific doses?

What is cagrilintide and retatrutide?

Retatrutide and cagrilintide are advanced, investigational injectable peptide medications designed for chronic weight management and metabolic conditions. While retatrutide is a single “triple-agonist” molecule targeting three metabolic receptors, cagrilintide is a long-acting analog of the satiety hormone amylin.

Luxara Labs +6
Retatrutide Mechanisms and Effects
  • Triple Receptor Activation: Binds simultaneously to GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.
    Drugs.com
  • Energy Expenditure: The added glucagon receptor activity helps increase calorie burn and break down liver fat.
    Creative Peptides +1
  • Clinical Efficacy: Phase clinical trials have shown substantial average body weight reductions exceeding 24% over extended treatment periods
    .

    Creative Peptides +1
Cagrilintide Mechanisms and Effects
  • Amylin Analog: Mimics human amylin, a natural hormone released by the pancreas alongside insulin to signal fullness to the brain.
  • Delayed Gastric Emptying: Slows down the rate at which food leaves the stomach, prolonging post-meal satiety.
  • Combination Potential: Frequently studied in synergy with incretin backbones (such as semaglutide in CagriSema or paired alongside retatrutide) to attack appetite via separate neurological pathways.
    www.retaweightloss.com +3
Common Side Effects
  • Gastrointestinal: Nausea, vomiting, diarrhea, and constipation.
  • Other Responses: Potential for transient increases in heart rate or localized injection site reactions.
    National Institutes of Health (NIH) | (.gov)

Is cagrilintide better than retatrutide?

In clinical trial data, retatrutide generally shows higher peak weight-loss efficacy than cagrilintide used alone. However, comparing them directly is complex because cagrilintide is primarily studied and used as a combination therapy (CagriSema, paired with semaglutide), whereas retatrutide is a single-molecule triple receptor agonist.

Bolt Pharmacy +3
How They Work
  • Cagrilintide: A long-acting amylin analogue that slows stomach emptying and promotes a feeling of fullness. It is typically tested alongside the GLP-1 receptor agonist semaglutide.
    Bolt Pharmacy +1
  • Retatrutide: A single “triple-agonist” peptide that simultaneously targets GLP-1, GIP, and glucagon receptors to curb appetite, manage blood sugar, and increase calorie burning (energy expenditure).
    Bolt Pharmacy
Clinical Efficacy and Trial Results
  • Retatrutide: Phase 3 clinical data have shown remarkable weight reduction reaching up to roughly 28.7% of body weight, making it one of the most potent single agents studied for obesity.
  • Cagrilintide (as CagriSema): Combined treatment of cagrilintide and semaglutide has shown robust weight loss around 20% to 23% in major trials, which is an improvement over older standard GLP-1 drugs, though trailing retatrutide’s peak trial numbers.
    Longevity.Technology +1
  • Cagrilintide alone: Produces lower standalone weight reduction (roughly 11%) compared to multi-agonist approaches.
    YouTube·Dr. Dan | Obesity Expert
Status and Safety
  • Approval Status: Neither drug is fully licensed or universally approved for general commercial prescription as standard-of-care obesity treatment; both continue to be evaluated through ongoing clinical trial programs.
    Bolt Pharmacy +1
  • Side Effects: Both share common gastrointestinal side effects like nausea, vomiting, and diarrhea, though their distinct receptor profiles mean researchers track different specific secondary risks (such as heart rate changes with glucagon activity or gallbladder considerations with amylin combinations).
    Bolt Pharmacy +2

For diluting lyophilized peptide powders, use a sterile and suitable research solvent such as bacteriostatic water (BAC), which may help support handling stability and reduce contamination risk.

For convenient laboratory use, see Bacteriostatic water 10ml.

Why Limitless Biochem?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “Retatrutide/Cagrilitide 10 mg + 5 mg”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Panier

Save to list